 von Willebrand factor head neck cancer Laboratory abnormalities blood coagulation factors common patients cancer significance unknown Twenty-eight patients head neck cancer time diagnosis Twenty-five advanced-stage III IV patients Levels factors antithrombin III plasminogen normal Levels von Willebrand factor vWF antigenic functional ristocetin cofactor group patients minimum months median months Fifteen patients follow-up period von Willebrand factor levels survivors Extreme elevation ristocetin cofactor U/dl patients none survivors Plasma vWF head neck cancer level time diagnosis prognostic therapeutic implications